SOX17 Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary Hypertension.

SOX17 Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary Hypertension. Circulation. 2023 05 23; 147(21):1606-1621.

View in: PubMed

subject areas

Animals
Endothelial Cells
Familial Primary Pulmonary Hypertension
Genome-Wide Association Study
HMGB Proteins
Hypertension, Pulmonary
Hypoxia
Mice
Pulmonary Artery
SOXF Transcription Factors
Transcription Factors

authors with profiles

Christopher J. Rhodes